4 recruiting, 1 enrolling by invitation. 3 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
| Not applicable | 1 | Recruiting 1 |
Follow Cadonilimab: new trials by email Literature Review of Cadonilimab trials Research Report on Cadonilimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix Cervix Cancer, Cadonilimab | Enrolling by invitation | Ding Ma | 20 | 2025-02-01 | 2025-02-06 | |
| Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer Cadonilimab - Triple-negative Breast Cancer, Cadonilimab | Phase 2 | Recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 27 | 2024-05-01 | 2025-05-20 |
| NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC Nanoliposomal Irinotecan+Oxaliplatin +Capecitabine+Cadonilimab - Nanoliposomal Irinotecan, Cadonilimab | Phase 2 | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 30 | 2024-04-17 | 2024-12-24 |
| Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases Cadonilimab, Bevacizumab, Cryoablation - Hepatocellular Carcinoma, Liver Cancer Stage IV | Not applicable | Recruiting | Sun Yat-sen University | 80 | 2024-02-02 | 2024-02-20 |
| Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer Cadonilimab + bevacizumab + FOLFOX - Metastatic Colorectal Cancer, Microsatellite Stable Colorectal Carcinoma | Phase 2 | Recruiting | Fudan University | 53 | 2024-01-01 | 2024-01-23 |
Carcinoma, Hepatocellular (1) · Colorectal Neoplasms (1) · Liver Neoplasms (1) · Triple Negative Breast Neoplasms (1) · Uterine Cervical Neoplasms (1)
Neoplasms (4) · Neoplasms by Site (4) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Adenocarcinoma (1) · Breast Diseases (1) · Breast Neoplasms (1) · Carcinoma (1) · Colonic Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Genital Diseases (1) · Genital Diseases, Female (1)
Bevacizumab (2) · Cryosurgery (1) · Folfox protocol (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Ding Ma (1) · Fudan University (1) · Sun Yat-sen University (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)
China (5)
Jinhua Huang, MD (1) · Yanxia Zhao, PhD (1) · Zhimei Hunag, MD (1)